Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Xampla Limited is managing 3 pending office actions in the Chemistry & Materials technology area. These actions are distributed among 3 distinct examiners, providing a diverse set of reviews for the company's materials-based innovations. The prosecution activity is split between 2 distinct art units, indicating that the portfolio covers multiple technical sub-specialties. This distribution across 2 distinct art units requires the applicant to adapt to different examination environments while managing these 3 pending office actions. Practitioners should be prepared for the technical variety presented by the 2 distinct art units.
The busiest examiner, MRUK, BRIAN P, is currently overseeing 1 pending office action. With 3 distinct examiners for the 3 total pending actions, the company's workload is evenly spread among different officials. This structure ensures that each of the 3 pending office actions receives an independent evaluation. Practitioners should be prepared for the individual styles of the 3 distinct examiners across the 2 distinct art units. The 3 pending office actions represent a strategic effort to secure patents across different segments of the chemistry and materials sector. This decentralized arrangement provides the company with multiple independent perspectives on its materials innovations.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| §112 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MRUK, BRIAN P | 1 | 74.2% | +27.9% |
| MORNHINWEG, JEFFREY P | 1 | 36.3% | +32.1% |
| XU, JIANGTIAN | 1 | 65.3% | +35.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18025441 | PROTEIN DISPERSIONS | XU, JIANGTIAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18844862 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | MRUK, BRIAN P | — |
| 18704514 | PLANT PROTEIN-STARCH FILMS | MORNHINWEG, JEFFREY P | — |
| 18025441 | PROTEIN DISPERSIONS | XU, JIANGTIAN | — |
| Art Unit | Apps |
|---|---|
| 1792 | 1 |
| 1762 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18844862 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | MRUK, BRIAN P | — | §112 | Final Rejection | — | Pending | Sep 06, 2024 |
| 18704514 | PLANT PROTEIN-STARCH FILMS | MORNHINWEG, JEFFREY P | 1792 | §103 | Non-Final OA | — | Pending | Apr 25, 2024 |
| 18025441 | PROTEIN DISPERSIONS | XU, JIANGTIAN | 1762 | §102§103§112 | Non-Final OA | — | Pending | Mar 09, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial